Dr. Reddy's Laboratories Limited Stock price

Equities

DRREDDY

INE089A01023

Pharmaceuticals

Market Closed - Bombay S.E. 05:24:57 2024-02-23 am EST 5-day change 1st Jan Change
6,445 INR +1.27% Intraday chart for Dr. Reddy's Laboratories Limited +2.04% +11.16%
Sales 2024 * 278B 3.36B Sales 2025 * 298B 3.6B Capitalization 1,060B 12.79B
Net income 2024 * 54.4B 656M Net income 2025 * 56.38B 680M EV / Sales 2024 * 3.54 x
Net cash position 2024 * 72.87B 879M Net cash position 2025 * 112B 1.35B EV / Sales 2025 * 3.18 x
P/E ratio 2024 *
19.5 x
P/E ratio 2025 *
18.8 x
Employees 25,863
Yield 2024 *
0.63%
Yield 2025 *
0.65%
Free-Float 91.47%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Dr. Reddy's Laboratories Limited

1 day+1.27%
1 week+2.04%
Current month+5.29%
1 month+13.70%
3 months+14.20%
6 months+8.25%
Current year+11.16%
More quotes
1 week
6 235.00
Extreme 6235
6 494.95
1 month
5 683.20
Extreme 5683.2
6 494.95
Current year
5 523.45
Extreme 5523.45
6 494.95
1 year
4 298.40
Extreme 4298.4
6 494.95
3 years
3 655.00
Extreme 3655
6 494.95
5 years
2 352.00
Extreme 2352
6 494.95
10 years
1 888.00
Extreme 1888
6 494.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 18-04-01
Director of Finance/CFO - 20-11-01
Chairman 56 93-01-17
Members of the board TitleAgeSince
Chairman 63 86-04-07
Chairman 56 93-01-17
Director/Board Member 73 07-06-04
More insiders
Date Price Change Volume
24-02-23 6,445 +1.27% 9 945
24-02-22 6,364 +0.24% 6,381
24-02-21 6,348 -0.44% 4,982
24-02-20 6,377 -0.60% 4,019
24-02-19 6,415 +1.57% 7,466

Delayed Quote Bombay S.E., February 23, 2024 at 05:24 am EST

More quotes
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows: - sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines; - sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services; - other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc. Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
36
Last Close Price
6,364 INR
Average target price
5,958 INR
Spread / Average Target
-6.37%
Consensus
1st Jan change Capi.
+11.16% 12 784 M $
+32.03% 693 B $
+22.09% 552 B $
+2.37% 386 B $
+18.57% 328 B $
+14.05% 312 B $
-5.89% 209 B $
+6.99% 210 B $
-5.15% 197 B $
-4.31% 156 B $
Other Pharmaceuticals
  1. Stock
  2. Equities
  3. Stock Dr. Reddy's Laboratories Limited - Bombay S.E.
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer